Gasp1: A Follistatin Domain Containing Protein

Abstract

The present invention relates to the use of a protein, GASP1, comprising at least one follistatin domain to modulate the level or activity of growth and differentiation factor-8 (GDF-8). More particularly, the invention relates to the use of GASP1 for treating disorders that are related to modulation of the level or activity of GDF-8. The invention is useful for treating muscular diseases and disorders, particularly those in which an increase in muscle tissue would be therapeutically beneficial. The invention is also useful for treating diseases and disorders related to metabolism, adipose tissue, and bone degeneration.


Claims
Owners (US)

Information currently unavailable.

IPC Classifications
Download PDF
Document Preview
Document History
  • Publication: Sep 8, 2009
  • Application: Jan 4, 2005
    US US 2805805 A
  • Priority: Jan 4, 2005
    US US 2805805 A
  • Priority: Feb 21, 2003
    US US 36973603 A
  • Priority: Dec 20, 2002
    US US 43464402 P
  • Priority: Feb 21, 2002
    US US 35784502 P

Download Citation


Sign in to the Lens

Feedback